AIDS

April 2003 - Volume 17 - Supplement 1

Email to a Colleague

Your Name: (optional)

Your Email:

Colleague's Email:

Separate multiple e-mails with a (;).

Message:
Thought you might appreciate this item(s) I saw at AIDS.

Send a copy to your email

Your message has been successfully sent to your colleague.

Some error has occurred while processing your request. Please try after some time.

• Clinical and biological insights in HIV-associated cardiovascular disease in the era of highly active antiretroviral therapy
• HIV therapy in 2003: consensus and controversy
• Pathogenesis of HIV-associated heart disease
• Immunopathogenesis of HIV-related heart muscle disease: current perspectives
• Mediators in HIV-associated cardiovascular disease: a focus on cytokines and genes
• Use of the transgenic mouse in models of AIDS cardiomyopathy
• Incidence of the involvement of the cardiovascular system in HIV infection
• HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era
• Atherosclerosis and HIV in the highly active antiretroviral therapy era: towards an epidemic of cardiovascular disease?
• Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era
• Kawasaki-like syndromes and other vasculitic syndromes in HIV-infected patients
• Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy
• Clinical and therapeutical follow-up of HIV-associated pulmonary hypertension: prospective study of 10 patients
• Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients
• Effect of exercise and strength training on cardiovascular status in HIV-infected patients receiving highly active antiretroviral therapy
• Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy
• HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management
• Clinical impact of HIV-related lipodystrophy and metabolic abnormalities on cardiovascular disease
• Cytokine production in women with antiretroviral treatment-associated breast fat accumulation and limb wasting
• Evaluation and management of metabolic and coagulative disorders in HIV-infected patients receiving highly active antiretroviral therapy
• The Pavia consensus statement